The effect of acyclovir [9-(2- Acyclovir [ACV; 9-(2-hydroxyethoxymethyl)guanine] is one of a new class of potent antiviral compounds recently shown to be effective against herpes simplex virus replication (4) and is one of a series of synthetic acyclic nucleoside compounds (28) . ACV has a potent inhibitory activity against herpes simplex virus-infected cells but has low toxicity for normal cells. The effect of ACV on another herpesvirus, EpsteinBarr virus (EBV), has not been reported previously.
EBV infects all human populations and causes infectious mononucleosis (5, 8, 13) , a disease characterized by infection and transformation of B-lymphocytes (16, 17, 23) and by EBV-determined nuclear antigen expression (27) . EBV is also uniquely associated with Burkitt lymphoma and nasopharyngeal carcinoma, two human malignancies. Tissues from such tumor sources carry multiple latent copies of EBV DNA (21, (35) (36) (37) . Because of its remarkable association with these clinical diseases and its transformation abilities in vitro, EBV is considered by many to be a prime human tumor virus candidate. Until now there has been no drug available which possesses potent antiviral activity without having serious deleterious effects on normal cell replication.
Our studies were designed to determine the effects of ACV on EBV DNA replication in the virus-producing cell line P3HR-1, in the non- (12) (13) (14) were performed by the method of Henle and Henle (12) ; EA-VCA+ (Kampala) and EA' VCA+ (Ghana) sera were used in the assays.
Preparation of P3HR-1 virus and viral DNA.
Preparation of virus for superinfection, procedures for superinfection, and purification of DNA from P3HR-1 virus have been described previously (1, 31 Hybridization. P3HR-1 and Raji cultures treated for 7 days with 100 ,uM ACV and mock-treated cultures were analyzed by in situ cytohybridization, as described previously (24) . Complementary RNA-DNA hybridization, which was used to quantitate EBV DNA and to locate EBV DNA on CsCl gradients, was conducted as previously described (21) .
Electron microscopy and contour length measurements. Open circular EBV DNA was spread onto Parlodian-coated grids (200-mesh copper; Pelco) by a modification of the microdiffusion technique (18) . In addition to EBV DNA, the spreading solution contained 0.50 M ammonium acetate (pH 7.5) and 60,ug of cytochrome c per ml. Simian virus 40 (SV40) form II DNA was included as an internal size marker.
Contour lengths of open circular DNA molecules were determined by projecting electron micrographs onto a Hewlett-Packard 986A digitizer tablet and tracing the DNA images with a cursor electronically coupled to a Hewlett-Packard 9825 calculator. VOL. 34, 1980 on November 6, 2017 by guest http://jvi.asm.org/ Downloaded from P3HR-1 virus leads to replication of EBV DNA, to suppression of cellular DNA synthesis, and to fragmentation of cellular DNA (22, 31, 34) . Such results are shown in Fig. 2A ; superinfection of Raji cells with EBV inhibited host cell DNA synthesis, whereas EBV DNA was synthesized. DNA synthesis was measured as the number of counts incorporated into the DNA banding at 1.718 g/cm3, the density of viral DNA. Addition of 100 MM ACV to the cultures 1 h after superinfection caused complete suppression of EBV DNA synthesis (Fig. 2A) Figure 3 shows that the dose required for 50% inhibition (ED5o) of viral DNA synthesis was 7 ,uM.
RESULTS

Effects
Reduction of viral genomes in P3HR-1 cells by ACV. Figure 4 shows the effect of ACV on viral genomes in P3HR-1 and Raji cells cultured for 7 The effect of drug removal on the number of EBV genomes was determined. After drug treatment for 7 days, all cultures were suspended in fresh medium lacking ACV. At 14 days after drug removal, the number of EBV genome equivalents per cell in all cultures had returned to the control levels (Fig. 4) h Hybridization was conducted as described previously (21) with DNA from P3HR-1 and Raji cells maintained for 7 days in the presence of various ACV concentrations. On day 7 the remaining cells were pelleted, washed, and placed in drug-free medium; genome levels for the same cultures were determined on day 22 Characterization of EBV DNA remaining in P3HR-1 cells after drug treatment. After 10 days, some EBV DNA remained in ACVtreated P3HR-1 cells. The EBV DNA remaining was characterized by isopycnic centrifugation and electron microscopy. Figure 6A shows that a significant quantity of the ACV-resistant viral DNA banded at the position expected for covalently closed circular molecules (1.59 g/cm3) when analyzed by ethidium bromide-cesium chloride density gradient centrifugation. Some EBV DNA banded between 1.56 and 1.57 g/cm:, the position of open circular and linear DNAs. The EBV DNA from the peak representing covalently closed circular DNA was isolated and fractionated on a second cesium chloride density gradient without ethidium bromide (Fig. 6B) . This DNA rebanded as a single peak at the bouyant density expected for EBV DNA; the DNA from this peak was isolated and visualized by electron microscopy ( Fig. 7 and 8 ). Figure 7 shows a covalently closed circular supercoiled DNA molecule recovered from drug-treated P3HR-1 cells, and Fig. 8 (3.4 x 106) was calculated for these studies from a precise nucleotide sequence analysis of SV40 DNA (9, 26) . The mean values obtained for the molecular weights of EBV DNAs from Raji and ACV-treated P3HR-1 cells were 111 x 106 ± 1.8
x 106 and 108 x 106 ± 2.1 x 106, respectively.
The distribution of molecular weights is shown in Fig. 9 . DISCUSSION ACV has little cytotoxicity for lymphoblastoid cells at the concentration (100 ,uM) necessary for complete inhibition of EBV DNA synthesis. A slight delay in cell replication is noted for Raji and P3HR-1 cells immediately after suspension in medium containing 100 yM ACV; however, 6 1.60-: the cell densities return to control levels within 7 days in the continued presence of the drug (Fig. 1) These results are comparable to those obtained by treating Raji, P3HR-1, and superinfected Raji cells with PAA (29, (32) (33) (34) , although the effective dose of PAA was sevenfold greater than the concentration of ACV used in these studies.
As ACV and PAA inhibit only the productive replication of EBV, they may have similar mechanisms of action, even though these two antiviral compounds are structurally dissimilar. It will be interesting to determine whether ACV or its phosphorylated derivatives inhibit EBV DNA replication by binding to a virus-specific DNA polymerase, as has been suggested for the mechanism of action of PAA in the herpes simplex virus (HSV) system (20) , or whether it inhibits EBV DNA synthesis by chain termination. ACV, an acyclic nucleoside analog of guanosine, is phosphorylated in HSV-infected cells to mono-, di-, and triphosphates (4) . ACV is also phosphorylated in superinfected Raji cells, but the level of phosphorylation is considerably lower than that observed in HSV-infected cells (unpublished data). The formation of ACV monophosphate in HSV-infected cells is a result of virus-induced thymidine kinase activity in these cells (4 This is close to the molecular weight ( 111 x 106) which we obtained for the episomal DNA of the non-virus-producing cell line Raji. A previous estimate for the molecular weight of EBV DNA from Raji cells was 106 x 10' (19). However, this measurement was determined by prior selection of DNA from glycerol gradients. We may have detected the larger forms of molecules in Raji cells because our isolation procedure did not preselect covalently closed EBV DNA molecules on the basis of size. The presence of covalently closed circular EBV DNA with an average molecular weight of 100 x 106 in PAA-treated P3HR-1 cells has been reported recently (11) . Our molecular weight values are based on SV40 DNA as the internal size reference. The values reported previously for Raji and P3HR-1 circular viral DNAs were determined by using PM2 DNA as the size reference.
In conclusion, ACV inhibits the productive replication of EBV DNA but has no apparent effect on the latent EBV genomes in cultured lymphoblastoid cell lines. Consistent with this fact, it has been possible to demonstrate the presence of ACV-resistant covalently closed circular EBV DNA in the P3HR-1 cell line. Because of its low cytotoxicity, ACV is a useful tool for the elucidation of cellular and viral processes related to EBV replication and to viral DNA persistence in latently infected cells. Its potential as a clinically useful antiherpetic agent is currently under assessment.
